top of page
1744991936937.jpeg

VerAvanti Insights

Thoughts, updates, and perspectives from our team and leadership.

What a Clear View Ahead Changes: A Cited Map of Where Forward Visualization Adds Value in PCI

Juan Vegarra

Defense & Aerospace Weekly

When the Wire Goes Quiet: Why CTO Pitfalls Are Orientation Failures, and What Looking Forward Can and Cannot Change

Juan Vegarra

Defense & Aerospace Weekly

Navigation Was Step One. Confirmation Is Step Two.

Juan Vegarra

Defense & Aerospace Weekly

The Last Frontier Is a Visibility Problem

Juan Vegarra

Defense & Aerospace Weekly

Imaging Shows Where You Are. The Missing View Is What Lies Ahead.

Juan Vegarra

Defense & Aerospace Weekly

The Data Moat Nobody Has

Juan Vegarra

Defense & Aerospace Weekly

FDA Clearance Is Not a Business Model

Juan Vegarra

Defense & Aerospace Weekly

The Discipline That Builds a Durable MedTech Company

Juan Vegarra

Defense & Aerospace Weekly

The MedTech Staircase: How Value Actually Builds

Juan Vegarra

Defense & Aerospace Weekly

Building the Commercial Engine

Juan Vegarra

Defense & Aerospace Weekly

In Medical Devices, Reimbursement Is the Real Product

Juan Vegarra

Defense & Aerospace Weekly

Go-to-Market Begins in the Procedure Room

Juan Vegarra

Defense & Aerospace Weekly

Four Signals a Market Is About to Reorder

Juan Vegarra

Defense & Aerospace Weekly

Drug-Eluting Balloons Are Changing What the Imaging Pullback Has to Answer

Juan Vegarra

Defense & Aerospace Weekly

The Quiet Shift: Intravascular Imaging Is Becoming a Decision Tool, Not a Report Card

Juan Vegarra

Defense & Aerospace Weekly

Stage IA Lung Cancer Has a 90% Survival Rate. Most Patients Never Get the Chance

Juan Vegarra

Defense & Aerospace Weekly

PAD By the Numbers: A Decade-Long Imaging Gap, Quantified

Defense & Aerospace Weekly

Why heart disease deserves a different bet.

Juan Vegarra

Defense & Aerospace Weekly

We Still Treat the Legs From a Lumenogram.

Juan Vegarra

Defense & Aerospace Weekly

Why the Same Technology Isn’t Used the Same Way Everywhere

Juan Vegarra

Defense & Aerospace Weekly

Something Doesn’t Add Up in the Cath Lab

Juan Vegarra

Defense & Aerospace Weekly

Stay Focused or Pivot

Juan Vegarra

Defense & Aerospace Weekly

The Scope Stops. The Nodule Doesn't.

Juan Vegarra

Defense & Aerospace Weekly

What It Actually Takes to Prepare for an Institutional Capital Raise

Juan Vegarra

Defense & Aerospace Weekly

The Cherry-Picker Manifesto Is Wrong.

Juan Vegarra

Defense & Aerospace Weekly

The Fallopian Tube Imaging Problem

Juan Vegarra

Defense & Aerospace Weekly

Beyond the Number: Why Your Calcium Score Is the Alarm, Not the Answer

Juan Vegarra

Defense & Aerospace Weekly

The RENOVATE-COMPLEX-PCI 5-Year Data Defines Both the Proof of Concept and the Engineering Brief for the Next Generation of Intravascular Imaging

Juan Vegarra

Defense & Aerospace Weekly

The SFE Advantage in Spinal Cord Stimulation Lead Placement

Juan Vegarra

Defense & Aerospace Weekly

The Anterior Epidural Blind Spot: Why Cervical ELND Has Stalled — and What Forward-Looking Visualization Changes

Juan Vegarra

Defense & Aerospace Weekly

The Visualization Ceiling in Lumbar ELND — and What Happens When You Remove It

Juan Vegarra

Defense & Aerospace Weekly

Fifty Million Patients. The Same Blind Spot. Why VerAvanti Is Building What Spinal Pain Care Has Always Needed.

Juan Vegarra

Defense & Aerospace Weekly

Seeing Forward: Clinical Applications of the Scanning Fiber Endoscope with Forward-Looking OCT

Juan Vegarra

Defense & Aerospace Weekly

The Most Complex PCI You Can Do — Without Harming the Kidneys

Juan Vegarra

Defense & Aerospace Weekly

The Blind Spot in the Cath Lab

Juan Vegarra

Defense & Aerospace Weekly

The Future of Interventional Cardiology: Why Multi-Modal Imaging Points to SFE’s Critical Role

Juan Vegarra

Defense & Aerospace Weekly

How SFE Technology Will Address the Bacteria-Heart Disease Connection

Juan Vegarra

Defense & Aerospace Weekly

How VerAvanti's SFE Technology Could Solve Critical Issues in Coronary Bifurcation Interventions

Juan Vegarra

Defense & Aerospace Weekly

Maximizing Value, Minimizing Cost

Juan Vegarra

Defense & Aerospace Weekly

The $100,000 Tooth

Juan Vegarra

Defense & Aerospace Weekly

From OR to Office

Juan Vegarra

Defense & Aerospace Weekly

The Zero-Repair Revolution

Juan Vegarra

Defense & Aerospace Weekly

The Economics of Precision

Juan Vegarra

Defense & Aerospace Weekly

The Gold Standard Margin

Juan Vegarra

Defense & Aerospace Weekly

The Next Leap in Minimally Invasive Surgery

Juan Vegarra

Defense & Aerospace Weekly

From Global Manufacturing to Clinical Mastery

Juan Vegarra

Defense & Aerospace Weekly

Shaping Modern Care

Juan Vegarra

Defense & Aerospace Weekly

The Convergence of Innovation and Scale

Juan Vegarra

Defense & Aerospace Weekly

A Region in Transformation and the Dawn of Advanced Diagnostics

Juan Vegarra

Defense & Aerospace Weekly

From Rigid Tubes to Real-Time Views

Juan Vegarra

Defense & Aerospace Weekly

Beyond The Price Tag

Juan Vegarra

Defense & Aerospace Weekly

A New Era of Vision

Juan Vegarra

Defense & Aerospace Weekly

The Great Paradox

Juan Vegarra

Defense & Aerospace Weekly

The Final Frontier

Juan Vegarra

Defense & Aerospace Weekly

VerAvanti's SFE and Peripheral Arterial Disease

Patrick McVeigh

Defense & Aerospace Weekly

Transformative Applications Across Medical Disciplines

Juan Vegarra

Defense & Aerospace Weekly

In-depth Look at VerAvanti's Scanning Fiber Endoscope

Juan Vegarra

Defense & Aerospace Weekly

Why Interventionalists Are Medicine's True Heroes

Juan Vegarra

Defense & Aerospace Weekly

The Future of Intravascular Imaging

Juan Vegarra

Defense & Aerospace Weekly

History of Intravascular Imaging

Juan Vegarra

Defense & Aerospace Weekly

bottom of page